Tot Biopharm, a private equity-backed Chinese biopharmaceutical company, has filed for an initial public offering (IPO) in Hong Kong on Monday under the rules that allow pre-profit companies to float shares on the stock exchange. The company did not disclose how many shares it intends to offer, and how much it seeks to raise. But […]

Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO comes originally from China Money Network. All Rights Reserved.